{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:16:35Z","timestamp":1791890195306,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.trre.2023.100800","type":"journal-article","created":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T03:19:00Z","timestamp":1696648740000},"page":"100800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Non-tuberculous mycobacteria disease pre-lung transplantation: A systematic review of the treatment regimens and duration pre- and post-transplant."],"prefix":"10.1016","volume":"37","author":[{"given":"Johanna P.","family":"van Gemert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofanne J.","family":"Ravensbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik A.M.","family":"Verschuuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huib A.M.","family":"Kerstjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte W.M.","family":"Willemse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakko","family":"van Ingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Hoefsloot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tji","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onno W.","family":"Akkerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2023.100800_bb0005","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1513\/AnnalsATS.201709-727OC","article-title":"Epidemiology of pulmonary nontuberculous mycobacterial sputum positivity in patients with cystic fibrosis in the United States, 2010-2014","volume":"15","author":"Adjemian","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.trre.2023.100800_bb0010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1164\/rccm.201405-0884OC","article-title":"Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk","volume":"190","author":"Adjemian","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trre.2023.100800_bb0015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/thx.39.5.369","article-title":"Mycobacterial isolations in young adults with cystic fibrosis","volume":"39","author":"Smith","year":"1984","journal-title":"Thorax"},{"key":"10.1016\/j.trre.2023.100800_bb0020","doi-asserted-by":"crossref","first-page":"2000535","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.trre.2023.100800_bb0025","first-page":"61","article-title":"Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation","author":"Chalermskulrat","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.trre.2023.100800_bb0030","first-page":"9","article-title":"Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection","author":"Gilljam","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.trre.2023.100800_bb0035","first-page":"27","article-title":"Lung transplant outcomes in cystic fibrosis patients with pre-operative Mycobacterium abscessus respiratory infections","author":"Lobo","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2023.100800_bb0040","first-page":"18","article-title":"Analysis of pulmonary non-tuberculous mycobacterial infections after lung transplantation","author":"Shah","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.trre.2023.100800_bb0045","first-page":"21","article-title":"Successful lung transplantation for chronic Mycobacterium abscessus infection in advanced cystic fibrosis, a case series","author":"Raats","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.trre.2023.100800_bb0050","first-page":"40","article-title":"Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation","author":"Leard","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2023.100800_bb0055","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/tid.12546","article-title":"Analysis of pulmonary non-tuberculous mycobacterial infections after lung transplantation","volume":"18","author":"Shah","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.trre.2023.100800_bb0060","first-page":"22","article-title":"Non-tuberculous mycobacteria in lung transplant recipients: prevalence, risk factors, and impact on survival and chronic lung allograft dysfunction","author":"Friedman","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.trre.2023.100800_bb0065","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1086\/514340","article-title":"Risk factors, clinical characteristics, and outcome of nocardia infection in organ transplant recipients: a matched case-control study","volume":"44","author":"Peleg","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.trre.2023.100800_bb0070","first-page":"57","article-title":"Eradication success for non-tuberculous mycobacteria in children with cystic fibrosis","author":"Hughes","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.trre.2023.100800_bb0075","doi-asserted-by":"crossref","first-page":"1800170","DOI":"10.1183\/13993003.00170-2018","article-title":"Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement","volume":"51","author":"van Ingen","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.trre.2023.100800_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2017.04.013","article-title":"Outcomes associated with antibiotic regimens for treatment of Mycobacterium abscessus in cystic fibrosis patients","volume":"16","author":"DaCosta","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.trre.2023.100800_bb0085","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.2015.3656","article-title":"Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD statement","volume":"313","author":"Stewart","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.trre.2023.100800_bb0090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijnurstu.2011.07.002","article-title":"Testing the reliability and efficiency of the pilot mixed methods appraisal tool (MMAT) for systematic mixed studies review","volume":"49","author":"Pace","year":"2012","journal-title":"Int J Nurs Stud"},{"key":"10.1016\/j.trre.2023.100800_bb0095","first-page":"61","article-title":"Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation","author":"Chalermskulrat","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.trre.2023.100800_bb0100","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.healun.2006.09.003","article-title":"Mycobacterium abscessus infections in lung transplant recipients: the international experience","volume":"25","author":"Chernenko","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2023.100800_bb0105","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.transproceed.2019.02.028","article-title":"Outcomes in lung transplant recipients with Mycobacterium abscessus infection: a 15-year experience from a large tertiary care center","volume":"51","author":"Hamad","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2023.100800_bb0110","first-page":"23","article-title":"Treatment outcomes of nontuberculous mycobacterial pulmonary disease in lung transplant recipients","author":"Hirama","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.trre.2023.100800_bb0115","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.healun.2011.02.007","article-title":"Non-tuberculous mycobacterium infection after lung transplantation is associated with increased mortality","volume":"30","author":"Huang","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2023.100800_bb0120","first-page":"22","article-title":"Outcome according to subspecies following lung transplantation in cystic fibrosis pediatric patients infected with Mycobacterium abscessus","author":"Kavaliunaite","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.trre.2023.100800_bb0125","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1399-3062.2012.00753.x","article-title":"Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study","volume":"14","author":"Knoll","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.trre.2023.100800_bb0130","first-page":"27","article-title":"Lung transplant outcomes in cystic fibrosis patients with pre-operative Mycobacterium abscessus respiratory infections","author":"Lobo","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2023.100800_bb0135","first-page":"20","article-title":"Mycobacterium abscessus infections in lung transplant recipients: 15-year experience from a single institution","author":"Osmani","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.trre.2023.100800_bb0140","first-page":"21","article-title":"Management and clinical outcomes after lung transplantation in patients with pre-transplant Mycobacterium abscessus infection: a single center experience","author":"Perez","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.trre.2023.100800_bb0145","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.transproceed.2012.02.035","article-title":"Nontuberculous mycobacterial disease is not a contraindication to lung transplantation in patients with cystic fibrosis: a retrospective analysis in a Danish patient population","volume":"45","author":"Qvist","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2023.100800_bb0150","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1399-3062.2009.00378.x","article-title":"Mycobacterium abscessus in cystic fibrosis lung transplant recipients: report of 2 cases and risk for recurrence","volume":"11","author":"Zaidi","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.trre.2023.100800_bb0155","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jcf.2010.03.008","article-title":"Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection","volume":"9","author":"Gilljam","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.trre.2023.100800_bb0160","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.healun.2006.04.003","article-title":"Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient","volume":"25","author":"Taylor","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2023.100800_bb0165","first-page":"7","article-title":"Novel administration of Clofazimine for the treatment of mycobacterium avium infection","author":"Valinetz","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.trre.2023.100800_bb0170","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trre.2023.100800_bb0175","article-title":"Epidemiology and management of nontuberculous mycobacterial disease in people with cystic fibrosis, the Netherlands","author":"Zomer","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.trre.2023.100800_bb0180","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2015-207360","article-title":"US Cystic Fibrosis Foundation and European cystic fibrosis society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis","volume":"71","author":"Floto","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.trre.2023.100800_bb0185","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcf.2012.06.009","article-title":"Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations","volume":"12","author":"Catherinot","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.trre.2023.100800_bb0190","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/archdischild-2021-322177","article-title":"Treating nontuberculous mycobacteria in children with cystic fibrosis: a multicentre retrospective study","volume":"107","author":"Saint","year":"2022","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.trre.2023.100800_bb0195","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/thx.2005.049247","article-title":"Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation","volume":"61","author":"Chalermskulrat","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.trre.2023.100800_bb0200","doi-asserted-by":"crossref","first-page":"1900798","DOI":"10.1183\/13993003.00798-2019","article-title":"Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study","volume":"55","author":"Jhun","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.trre.2023.100800_bb0205","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.chest.2021.08.046","article-title":"Mycobacterium growth Indicator tube time-to-positivity can serve as an early biomarker of treatment response in Mycobacterium avium complex pulmonary disease","volume":"161","author":"Danho","year":"2022","journal-title":"Chest"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X2300054X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X2300054X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T16:09:51Z","timestamp":1760630991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X2300054X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0955470X2300054X"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2023.100800","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-tuberculous mycobacteria disease pre-lung transplantation: A systematic review of the treatment regimens and duration pre- and post-transplant.","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2023.100800","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100800"}}